Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: risedronate sodium

« Back to Dashboard
Risedronate sodium is the generic ingredient in three branded drugs marketed by Warner Chilcott Llc, Apotex Inc, Mylan Pharms Inc, Sun Pharma Global, Teva Pharms, and Teva Pharms Usa, and is included in seven NDAs. There are ten patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

This ingredient has sixty-six patent family members in twenty-nine countries.

There are nineteen drug master file entries for risedronate sodium. Four suppliers are listed for this compound. There are five tentative approvals for this compound.

Summary for Generic Name: risedronate sodium

Tradenames:3
Patents:10
Applicants:6
NDAs:7
Drug Master File Entries: see list19
Suppliers: see list4
Therapeutic Class:Metabolic Bone Disease Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: risedronate sodium

Ingredient-typeDiphosphonates
Drug ClassBisphosphonate

Tentative approvals for RISEDRONATE SODIUM

Applicant Application No. Form Dosage
<disabled><disabled>TABLET; ORAL35MG
<disabled><disabled>TABLET;ORAL5MG
<disabled><disabled>TABLET;ORAL30MG

Clinical Trials for: risedronate sodium

You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near 'LIMIT 5' at line 4